Newly listed or thinly covered: fundamentals appear here once there is enough reported history. Prices and market cap are up to date.
Where does it rank among Health Technology peers?
Each cell is the company's percentile rank among its Health Technology peers (non-financial companies) that month.
Darker is better-ranked.
Rows marked ↓ are inverted (lower debt, shorter cash cycle and a lower P/E rank higher).
Where it ranks today
- ROCE54th
- Op. margin27th
- Debt/equity ↓3rd
- Cash cycle ↓55th
- P/E ↓58th
Rank history
Percentiles use today's listed companies in the sector and need at least 5 peers with a value; grey cells have too few.
ROE is computed from net profit and book value where the source does not report it.
The Health Technology sector page Watch it move against Health Technology in the Observatory
What is the price implying?
At a P/E of 65.5x, the price would imply about 29.8%/yr earnings growth for 10 years under the same assumptions, but it is not ranked.
Below the ₹1,000 cr market-cap floor used for the lists.
“Implied growth” is what the current price would require under our stated assumptions, not what we expect.
What prices imply across Health Technology The market-wide Expectations lists
Key figures
- Share Priceclose 9 Nov
- ₹33.42
- P/E
- 32.4x
- ROCE
- 15.0%
- Market Cap
- ₹851 cr
- Revenue (TTM)
- ₹732 cr
- P/S
- 1.2x
- P/B
- 5.5x
- ROE
- 16.9%
- Operating Margin
- 9.1%
- Debt / Equity
- 1.8x
- Promoter Holding
- 58.9%
Balance sheet & cash
Are profits backed by cash?
Other income reliance27%Near threshold
Other income as a share of pre-tax profit (trailing twelve months): 26.8%. Bands: below 15%, 15% to 35%, above 35%.
Tax rate—Not enough data
Not enough reported data to compute this.
Cash conversion-0.56xBeyond threshold
Operating cash flow divided by net profit over the last three fiscal years: -0.56x (cash from operations ₹-28 cr, net profit ₹50 cr). Bands: 0.8x and above, 0.5x to 0.8x, below 0.5x.
Free cash flow1 of 5 yrsBeyond threshold
Fiscal years with positive free cash flow in the last 5: 1. Bands: at least 80% of years, 40% to 80%, below 40%.
Receivable days vs history—Not enough data
Not enough reported data to compute this.
Capital work in progress3% of fixed assetsWithin range
Capital work-in-progress is 3% of fixed assets. Bands: not rising or up to 30%; rising for three years and above 30%; rising and above 60%.
Payable days—Not enough data
Not enough reported data to compute this.
Tap a check to see how it is measured
How to read this
Each check is a named rule with fixed thresholds, not a score. Annual statements are the latest restated figures, so a past year may differ from what was originally reported.
Monthly history2 months · 2026-10 to 2026-11
| Month | P/E | Revenue (TTM) | ROE | ROCE | Debt / Equity |
|---|---|---|---|---|---|
| 2026-11 | 32.4x | ₹732 cr | 16.9% | 15.0% | 1.8x |
| 2026-10 | 35.4x | ₹732 cr | 16.8% | 15.0% | 1.8x |